Hunan Province Tumor Hospital
Clinical trials sponsored by Hunan Province Tumor Hospital, explained in plain language.
-
New drug combo aims to shrink inoperable lung tumors enough for surgery
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and toripalimab, in 50 adults with stage III non-small cell lung cancer that cannot be surgically removed. The goal is to see if the treatment can shrink tumors enough to allow surgery and improve survival. Part…
Phase: PHASE2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated May 17, 2026 02:21 UTC
-
New combo aims to fight lung cancer that outsmarted earlier drugs
Disease control Not yet recruitingThis study tests a combination of limertinib (a targeted pill) plus two chemotherapy drugs (carboplatin and etoposide) in 30 adults with a specific type of lung cancer. These patients had non-small cell lung cancer with an EGFR mutation, but after initial targeted therapy stopped…
Phase: PHASE2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Can a simple drug help lung cancer patients keep their strength?
Symptom relief Not yet recruitingThis study tests whether adding megestrol acetate (a drug that stimulates appetite) to standard cancer treatment helps malnourished patients with non-small cell lung cancer gain weight. About 116 adults with advanced lung cancer will be randomly assigned to receive either standar…
Phase: PHASE3 • Sponsor: Hunan Province Tumor Hospital • Aim: Symptom relief
Last updated May 04, 2026 16:32 UTC